About Patheon
Patheon is a Healthcare company based in Durham (United States) founded in 1974 by Doug Sprague, and was acquired by Thermo Fisher Scientific in August 2017. Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry. It operates in the Healthcare and Transportation, Automotive & Logistics sectors. Patheon has raised $141 million across 4 funding rounds from investors including Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty and Advent Morro Equity Partners. Patheon has completed 2 acquisitions, including Banner Life Sciences and IRIX Pharmaceuticals. Its website patheon.com draws about 89 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Diversified and Transportation and Logistics. Its competitors include LakePharma, Maravai Life Sciences and Grand River Aseptic Manufacturing; 2 of its 3 listed competitors have raised funding.
Company details
Patheon provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries worldwide. Its commercial manufacturing activities relate primarily to prescription and OTC products in solid, semi-solid, liquid, and sterile dosage forms. The company also provides a range of specialised pharmaceutical development capability, including high-potency, sterile, lyophilization, and controlled-release. Patheon delivers products to approximately 120 countries and offers an array of services, including manufacturing, logistics, and packaging of conventional dosage forms, sterile dosage forms, and specialised products. Its contract pharmaceutical development services include pre-formulation, formulation and development of dosage forms; development of analytical methods; manufacture to customer specifications of proposed new drug products during the regulatory drug approval process, including the manufacture of pilot batches; clinical packaging; and scale-up and technology transfer services to validate commercial-scale drug manufacturing processes. Patheon was acquired by JLL Partners, a PE firm in 2013, merged with DSM Pharmaceutical Products in 2014 and went public in July 2016 on the NYSE. The company has a presence in 70 countries and claims to have been engaged in either the development or manufacturing of 25 of the top 100 drugs in the market as of 2016.
- Headquarters Durham, United States
- Founders Doug Sprague
- Stage Acquired
- SectorsHealthcareTransportation, Automotive & Logistics
- Website category Health · Biotechnology and Pharmaceuticals
- Website patheon.com/en-us
- Social LinkedIn X Facebook YouTube
- Acquired by Thermo Fisher Scientific (Aug 2017)
- Total Equity Funding$141M (USD)
in 4 rounds
- Latest Funding Round$903.72K (USD), Grant
Dec 2021
- InvestorsThermo Fisher Scientific
& 3 more
- Investments & AcquisitionsBanner Life Sciences
& 1 more
- Acquired byThermo Fisher Scientific
(Aug 2017)
Apps and channels of Patheon
its YouTube channel PatheonChannel has 929 subscribers and 30 videos.
Videos from Patheon
The most watched videos on Patheon's YouTube channel, PatheonChannel (929 subscribers). Click a video to play it here.
More on PatheonChannel.
Funding Insights of Patheon
Patheon has successfully raised a total of $141M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $903.72 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $141M
- Total Rounds 4
- Last Round Grant — $903,720
- First Round $138M
(Mar 2007)
- Investors Count 3
All 4 funding rounds of Patheon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $903,720 | Grant | – | – | |
| Apr 2010 | $280M | Post-IPO | – | – | – |
| Apr 2007 | $3M | Private Equity Round | – | – | |
| Mar 2007 | $138M | Private Equity Round | – | – |
4 investors in total: 4 institutional.
Investors in Patheon
Patheon has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty and Advent Morro Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage companies are targeted for private equity investments. | adventmorro.com | San Juan, Puerto Rico | ||
JLL Partners is engaged in middle-market business transformation and investment. | jllpartners.com | New York, United States | ||
| economie.gouv.fr | ||||
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for Patheon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Patheon
1282 people are tracked at Patheon (505 in leadership, 18 in board & advisors, 759 in team).
| Name | Role | Group |
|---|---|---|
Doug Sprague | Founder | Leadership |
Mike Shafer | SVP & President, Pharma Services | Leadership |
Nader Riad | Director, Advanced Engineering | Leadership |
Rachelle Sepich | Senoir HR Director | Leadership |
Benjamin Chong | Senior Director HR | Leadership |
Tony Farero | Director HR, Global Quality | Leadership |
David Reirden | VP, HR Productivity & Operations | Leadership |
Francis Baker | Senior Director, HR PMO & LR | Leadership |
Praveen Chauhan | Head Of Information Technology | Leadership |
James Niblock | Director, Managed Access Programs | Leadership |
Angela Thomas | Senior Director Growth & Strategy | Leadership |
Juan Semanate | Sr. Director - Operations | Leadership |
Lori Petersen | Senior HR Director | Leadership |
Jessika Fabiano | Director, Early Talent Programs | Leadership |
Stewart Han | Director, Marketing | Transplant Diagnostics | Leadership |
Sjoerd van Den Boom | Director Mechanical Sub-assemblies - Global Procurement Bij Thermo Fisher Scientific | Leadership |
Aaron Basey | Sr. Director Digital Product Management | Leadership |
Alexander Makarov | Director Global Research | Leadership |
Susanne Moyer | Vice President & General Manager | Leadership |
Jackie Reisner | Director, Biostatistics And Programming | Leadership |
1262 more people are available in the full profile.
Complete people profiles for Patheon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Patheon
Patheon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Banner Life Sciences and IRIX Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Difficult-to-manufacture APIs and complex intermediates are developed by IRIX Pharmaceuticals. | irixpharma.com | Florence, United States | 1996 | Mar 2015 | •••• | |
Fully integrated product development using its formulation technologies. | bannerls.com | High Point, United States | 1994 | Oct 2012 | $255M |
Complete acquisition details for Patheon
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Patheon
7 dated milestones of Patheon across 47 years, from founding to its latest funding, stage changes and deals.
- Founded Patheon is founded.
- Funding First funding round of $138.0M.
- Acquisition Acquires Banner Life Sciences.
- Acquisition Acquires IRIX Pharmaceuticals.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Thermo Fisher Scientific.
- Funding Latest funding round, Grant, of $904K.
Competitors of Patheon
Patheon has 3 listed competitors in our database, 2 of them funded. They include LakePharma, Maravai Life Sciences and Grand River Aseptic Manufacturing.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lakepharma.com | 2009 | Belmont, United States | $30M | 212 | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | |
| maravai.com | 2014 | San Diego, United States | 650 | Provides enabling tools and services in the life sciences research and bio-production industries | ||
| grandriverasepticmfg.com | 2010 | Grand Rapids, United States | $16.93M | 293 | Sterile parenteral CDMO services for development and manufacturing are offered. |
Detailed competitors of Patheon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Patheon
The website of Patheon (patheon.com) receives about 89.1K visits a month and ranks #488,648 among all websites worldwide, #475 in Biotechnology and Pharmaceuticals.
- Monthly visits89.1K
▲ 12.8% vs previous month
- Unique visitors36.3K
per month
- Global rank#488,648
among all websites
- Category rank#475
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.7
- Average visit20 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Patheon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| catalent.com | 100% | 116.7K | #338,870 | View details | |
| nebiolab.com | 83% | 20.8K | #944,903 | View details | |
| susupport.com | 82% | 45.6K | #727,525 | View details | |
| adragos-pharma.com | 79% | 37.7K | #765,754 | View details | |
| pfizer.com | 79% | 1.9M | #24,984 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Patheon
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Patheon (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Patheon
Complete news archive for Patheon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Patheon
Patheon was founded in 1974 and raised its 1st funding round 33 years after it was founded.
Patheon is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Patheon is a funded company, having raised a total of $141M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $138M, raised on Mar 2007.
Patheon provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries worldwide. Its commercial manufacturing activities relate primarily to prescription and OTC products in solid, semi-solid, liquid, and sterile dosage forms. The company also provides a range of specialised pharmaceutical development capability, including high-potency, sterile, lyophilization, and controlled-release. Patheon delivers products to approximately 120 countries and offers an array of services, including manufacturing, logistics, and packaging of conventional dosage forms, sterile dosage forms, and specialised products. Its contract pharmaceutical development services include pre-formulation, formulation and development of dosage forms; development of analytical methods; manufacture to customer specifications of proposed new drug products during the regulatory drug approval process, including the manufacture of pilot batches; clinical packaging; and scale-up and technology transfer services to validate commercial-scale drug manufacturing processes. Patheon was acquired by JLL Partners, a PE firm in 2013, merged with DSM Pharmaceutical Products in 2014 and went public in July 2016 on the NYSE. The company has a presence in 70 countries and claims to have been engaged in either the development or manufacturing of 25 of the top 100 drugs in the market as of 2016.
Patheon's top competitors include Grand River Aseptic Manufacturing, Maravai Life Sciences and LakePharma.
Patheon has made 2 acquisitions, including Banner Life Sciences, and IRIX Pharmaceuticals.
Patheon has 4 investors. Key investors include Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty, Advent Morro Equity Partners, and JLL Partners.
Yes. Patheon was acquired by Thermo Fisher Scientific in August 2017.